Low level lead and inhibition of erythrocyte pyrimidine nucleotidase

C R Angle1, M S McIntire

  • 1Department of Pediatrics, University of Nebraska Medical Center, Omaha.

Environmental Research
|October 1, 1978
PubMed

Insights

Pyrimidine 5'-nucleotidase (P5N) levels in red blood cells decrease with rising blood lead exposure in children and rats. This enzyme may serve as a sensitive biomarker for early lead poisoning detection.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pediatrics

Background:

  • Lead exposure is a significant public health concern, particularly in young children.
  • Sensitive biomarkers are needed for early detection of lead toxicity.
  • Pyrimidine 5 omino-nucleotidase (P5N) is an enzyme involved in nucleotide metabolism.

Purpose of the Study:

  • To investigate the potential of red blood cell Pyrimidine 5 omino-nucleotidase (P5N) as a sensitive biomarker for low-level lead exposure.
  • To establish the correlation between blood lead levels and P5N activity in both children and rats.

Main Methods:

  • Assessed P5N activity in red blood cells of children aged 2-5 years with varying blood lead levels.
  • Administered lead acetate to rats and monitored blood lead levels and P5N activity over 24 days.
  • Analyzed the correlation between blood lead concentrations and P5N activity, controlling for reticulocyte count.

Main Results:

  • A significant negative linear correlation was observed between blood lead levels and red cell P5N activity in children (r = -0.60, P < 0.01).
  • In rats, P5N activity decreased significantly with increasing blood lead levels (r = -0.85, P < 0.001), showing a similar trend to humans.
  • Lead exposure did not significantly alter hexokinase, hemoglobin, or red cell count at the measured levels.

Conclusions:

  • Red blood cell Pyrimidine 5 omino-nucleotidase (P5N) is a sensitive indicator of lead exposure, even at low levels.
  • P5N activity can be a valuable biomarker for early detection and monitoring of lead toxicity in both pediatric and animal models.
  • Further research can explore P5N's utility in clinical settings for lead poisoning surveillance.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...